Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for quick activation of LAK (Lymphokine activated killer) cells

A technology of lymphokines and killing cells, which is applied in the direction of animal cells, vertebrate cells, cell culture active agents, etc., and can solve problems such as weak lethality, multi-organ dysfunction, and large-scale infusion

Inactive Publication Date: 2018-11-06
淮安诺康生物科技有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, LAK is not lethal, and clinical application requires a large amount of infusion
Moreover, its expansion ability is limited, and large doses of IL-2 need to be applied at the same time as cell infusion, resulting in obvious toxic side effects. The most common and serious side effect is capillary leak syndrome, which is mainly manifested as generalized edema and multiorgan dysfunction, which can cause pleural and peritoneal effusions, pulmonary interstitial edema, and congestive heart failure
[0004] At present, LAK cells need to be cultured in vitro for at least 3 to 7 days. The process is long, expensive, and easily polluted, which limits clinical application. Therefore, the research on simple and fast induction culture has never stopped.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for quick activation of LAK (Lymphokine activated killer) cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0050] Embodiment 1: the preparation of polypeptide

[0051] 1. Defat wheat germ

[0052] Use defatted wheat germ, or directly purchase defatted wheat germ for subsequent experiments. Degreasing conditions: extractant: petroleum ether (60°C-90°C), water bath temperature: 65°C, solid-liquid ratio: 1:8 (g / mL), degreasing time: 4h.

[0053] The defatted wheat germ is pulverized into 80 meshes to obtain defatted wheat germ powder, which is set aside.

[0054] 2. Hydrolysis and purification of peptides

[0055] The defatted wheat germ powder was treated with papain (enzyme activity of 800,000 U / g) + neutral protease (enzyme activity of 200,000 U / g) at a compound ratio of 3:1 (mass ratio), pH of 6.0, and temperature Enzymolysis under the conditions of 55°C, substrate mass concentration 40g / L, enzyme addition amount 5% (100g substrate plus 5g enzyme), enzymolysis time 8h, after enzymolysis, the temperature was raised to 90°C and kept for 20min for enzymatic inactivation treatment ...

Embodiment 2

[0059] Embodiment 2: LAK cell rapid activation method

[0060] 1. Experimental materials

[0061] RPMI 1640 medium and 10% fetal bovine serum were purchased from Gibco.

[0062] rIL-2 was purchased from Beijing Sihuan Biopharmaceutical Company.

[0063] 2. Experimental method

[0064] 1. Umbilical cord blood collection and mononuclear cell isolation

[0065] The closed collection method was used to collect cord blood from 100 cases of healthy neonates born in full-term normal delivery, and the parents of the prenatal examinations had no family history of genetic diseases. It was collected from the side away from the neonatal side of the umbilical cord stump before delivery. After collection, they were stored in a refrigerator at 4°C, and separated and frozen within 24 hours.

[0066] With reference to the technical handbook in this field (Shen Caring etc., Modern Immunology Experimental Technology, Hubei Science and Technology Press, 1998, 172-175 pages), adopt Ficoll dia...

Embodiment 3

[0080] Embodiment 3: LAK cell rapid activation method

[0081] 1. Experimental materials

[0082] RPMI 1640 medium and 10% fetal bovine serum were purchased from Gibco.

[0083] rIL-2 was purchased from Beijing Sihuan Biopharmaceutical Company.

[0084] 2. Experimental method

[0085] 1. Umbilical cord blood collection and mononuclear cell isolation

[0086] The closed collection method was used to collect cord blood from 100 cases of healthy neonates born in full-term normal delivery, and the parents of the prenatal examinations had no family history of genetic diseases. It was collected from the side away from the neonatal side of the umbilical cord stump before delivery. After collection, they were stored in a refrigerator at 4°C, and separated and frozen within 24 hours.

[0087] With reference to the technical handbook in this field (Shen Caring etc., Modern Immunology Experimental Technology, Hubei Science and Technology Press, 1998, 172-175 pages), adopt Ficoll dia...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for quick activation of LAK (Lymphokine activated killer) cells. The method includes: adjusting cord blood mononuclear cells to 2*10<6> / mL by 10% fetal calf serum containing RPMI 1640 culture medium (10%FCS-RPMI 1640), performing inoculation in culture vessels different in capacity according to the total cell count while adding enzymolysis polypeptide A in final concentration of 40-60microgram / mL, enzymolysis polypeptide C or enzymolysis polypeptide D and 500IU / mL of rIL-2, and culturing for 24h under conditions of 37 DEG C and 5% CO2. The method has advantagesthat on the premise that high consumption of rIL-2 is avoided, quick activation of the LAK cells can be realized in 24h through adding of the enzymolysis polypeptide A, the enzymolysis polypeptide Cor the enzymolysis polypeptide D into the culture medium.

Description

technical field [0001] The invention belongs to the biological field and relates to a method for rapidly activating lymphokines to activate killer cells LAK. Background technique [0002] Immunotherapy is an emerging tumor treatment method, which has been listed as the fourth treatment method after surgery, radiotherapy, and chemotherapy, and is gradually playing an important role in the comprehensive treatment of tumors. In 2010, the US FDA approved Provenge, the world's first cellular immunotherapy product, to go on the market, fully demonstrating the value of cellular immunotherapy in tumor treatment. [0003] Lymphokine-activated killer cells (LAK) were developed in the 1980s by Rosenberg et al. Its essence is NK and T cells with tumoricidal activity activated by IL-2. In November 1984, Rosenberg's research group was approved by the US FDA to use LAK cells for clinical treatment for the first time. The therapy has been shown to be effective in patients with metastatic ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/0783C12P21/06C07K1/34
CPCC12N5/0638C07K1/34C12N2501/2302C12N2501/999C12P21/06
Inventor 何英广马思航
Owner 淮安诺康生物科技有限公司